http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103360312-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_653c418e41edbb4e1ce8bc5e53e70cec |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D225-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427 |
| filingDate | 2013-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c4bc3da8a9cb145dd4fe5bd1b03b0c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3fdf971f41a2d47439262503fb491a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f25efa78f0ed5edf4a665b6211a10d68 |
| publicationDate | 2015-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103360312-B |
| titleOfInvention | Geldanamycin derivative and its application |
| abstract | The invention discloses a geldanamycin derivative is a 17-mono-substituted or 17,19-disubstituted geldanamycin derivative, structural general formula of which is as shown in the formula (I). It is confirmed through experiments that the geldanamycin derivative maintains or increases its original antineoplastic activity and obviously reduces its hepatotoxicity, thus laying a foundation for research and development of an antitumor drug with the geldanamycin derivative used as a lead compound. |
| priorityDate | 2013-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.